Premium
Surgery and post‐operative radiotherapy for early stage cervical cancer
Author(s) -
Vinod S K.,
MacLeod C A.,
Dalrymple C,
Elliott P,
Atkinson K,
Carter J,
Firth I
Publication year - 2000
Publication title -
australian and new zealand journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.734
H-Index - 65
eISSN - 1479-828X
pISSN - 0004-8666
DOI - 10.1111/j.1479-828x.2000.tb03170.x
Subject(s) - medicine , radiation therapy , cervical cancer , stage (stratigraphy) , surgery , cancer , retrospective cohort study , incidence (geometry) , adjuvant radiotherapy , population , hysterectomy , paleontology , physics , environmental health , optics , biology
SUMMARY The use of post‐operative radiotherapy in the treatment of cervical cancer is controversial. The aim of this study was to document the results and toxicity of adjuvant irradiation in patients with Stage 1B and 2A cervical cancer. We performed a retrospective review of all patients treated with post‐operative radiotherapy at Royal Prince Alfred Hospital between 1986 and 1993. Patient, tumour and treatment factors and late toxicity were recorded. Relapse‐free and overall survival were calculated. Eighty‐one patients form the study population. The median follow‐up was 6.1 years. Fifty‐eight patients (72%) had stage 1B cervical cancer and 23 (28%) stage 2A. The 5 year relapse‐free and overall survival were 78% and 80% respectively. Six patients (7%) had late toxicity requiring inpatient medical treatment and 6 patients (7%) required surgery. The survival was comparable to other series reported in the literature. There was an incidence of 14% late toxicity requiring medical or surgical intervention which is greater than with hysterectomy or pelvic irradiation alone. Clinical prognostic factors should be used to select patients for either surgery or radiotherapy alone to minimise the increased toxicities associated with a combination of surgery and radiotherapy.